AN2 Therapeutics, Inc. (ANTX) News
Track canonical SquawkNews coverage tagged to ANTX, AN2 Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
AN2 Therapeutics Q2 EPS $(0.18) Beats $(0.27) Estimate
AN2 Therapeutics (NASDAQ: ANTX ) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.27) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.21) per share fro
EARNINGS | Aug 11, 2026, 08:33 PM UTC
L
moves among today's upgrades NBIS +7.3%, LITE +6.0%, AKTX +5.7%, URBN +3.1%, YETI +2.2%, HOG +1.8%, GPN +1.5%, USB +0.6%, NFLX -1.8% moves a
moves among today's upgrades NBIS +7.3%, LITE +6.0%, AKTX +5.7%, URBN +3.1%, YETI +2.2%, HOG +1.8%, GPN +1.5%, USB +0.6%, NFLX -1.8% moves among today's positive initiations NNBR +8.0%, RNTX +3.2%, SLNH +15.5%, ANTX +9.6
EQUITY | Jul 20, 2026, 01:42 PM UTC
L
ANTX Initiated Buy W/$9.00 PT at Guggenheim
ANTX Initiated Buy W/$9.00 PT at Guggenheim
EQUITY | Jul 20, 2026, 11:49 AM UTC
L
ANTX new Buy W/ $9 PT @ GUGG
ANTX new Buy W/ $9 PT @ GUGG
EQUITY | Jul 20, 2026, 11:43 AM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Wednesday's pre-market session, with Pulsenmore and Catheter Precision leading the gainers and Nuwellis and Mobile-health Network leading the losers
EQUITY | Jun 24, 2026, 12:09 PM UTC